Fundz

Alpha Fusion, Inc. raised ¥1.02 billion in a Series B funding round led by SBI Investment Co., Ltd. and OSAKA University Venture Capital to accelerate astatine-based drug discovery and enhance its supply chain.

PRIVATEOct 12, 2024

Amount Raised

¥102 Million

Round Type

Series B

OsakaBiotechnologyTherapeutics

Investors

Osaka University Venture CapitalSBI Investment Co., Ltd.

Description

Alpha Fusion, Inc. has successfully raised ¥1.02 billion through a Series B funding round aimed at advancing its research and development efforts. The funding will support the startup in delivering cutting-edge cancer therapies globally.

Quick answer

Alpha Fusion raised ¥102 Million in a Series B round, dated October 12, 2024. Investors: Osaka University Venture Capital and SBI Investment Co., Ltd. Alpha Fusion is based in Osaka, Osaka Prefecture, Japan.

How much did Alpha Fusion raise?
Alpha Fusion raised ¥102 Million in a Series B round on October 12, 2024.
Who invested in Alpha Fusion?
Osaka University Venture Capital and SBI Investment Co., Ltd. are named as investors in this round.
What does Alpha Fusion do?
Alpha Fusion, Inc. is a Japanese startup focusing on the development of Astatine-based therapeutics.
Where is Alpha Fusion based and how big is it?
Alpha Fusion is based in Osaka, Osaka Prefecture, Japan.
Who are the decision-makers at Alpha Fusion?
Fundz holds 1 contact at Alpha Fusion. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Alpha Fusion that raised within 45 days of this round, from Fundz verified event records.

  • Debiopharm raised $5.8M (Funding Round) on November 21, 2024.
  • Intensity Therapeutics raised $3.6M (Seed) on November 21, 2024.
  • Biofrontera raised $4.2M (Seed) on November 21, 2024.
  • HCW Biologics raised $6.9M on November 20, 2024.
  • Adipo Therapeutics raised $4.7M (Seed) on November 19, 2024.
  • ATB Therapeutics raised $57M (Series A) on November 18, 2024.

Who to call at Alpha Fusion, and when

A new round usually means Alpha Fusion is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Alpha Fusion raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Alpha Fusion, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Alpha Fusion. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Alpha Fusion

Location

Osaka, Osaka Prefecture, Japan

About

Alpha Fusion, Inc. is a Japanese startup focusing on the development of Astatine-based therapeutics. The company leverages research outcomes from Osaka University and the Japan Science and Technology Agency to advance its pipeline and enhance its supply chain. They aim to deliver cutting-edge cancer therapies to the global market by accelerating research and development efforts. Alpha Fusion is recognized as a leader in the clinical development of innovative drug discovery platforms in oncology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Alpha Fusion raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Alpha Fusion's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Alpha Fusion raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.